Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies

Research output: Contribution to journalReview article

49 Scopus citations

Abstract

Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.

Original languageEnglish (US)
Pages (from-to)207-222
Number of pages16
JournalGastroenterology Clinics of North America
Volume40
Issue number1
DOIs
StatePublished - Jan 1 2011

Keywords

  • Anti-inflammatories
  • Antibiotics
  • Gut microbiota
  • Prebiotics
  • Synbiotics

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies'. Together they form a unique fingerprint.

Cite this